UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Universal Health Services, Inc. (NYSE:UHS - Free Report) by 13.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 346,969 shares of the health services provider's stock after purchasing an additional 41,218 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.52% of Universal Health Services worth $79,459,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Cetera Investment Advisers lifted its stake in shares of Universal Health Services by 134.2% during the first quarter. Cetera Investment Advisers now owns 8,744 shares of the health services provider's stock valued at $1,595,000 after acquiring an additional 5,010 shares during the period. Cetera Advisors LLC acquired a new position in Universal Health Services during the 1st quarter valued at about $642,000. DekaBank Deutsche Girozentrale boosted its stake in shares of Universal Health Services by 33.6% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 4,521 shares of the health services provider's stock valued at $820,000 after purchasing an additional 1,138 shares during the last quarter. GAMMA Investing LLC grew its position in shares of Universal Health Services by 84.7% during the 2nd quarter. GAMMA Investing LLC now owns 665 shares of the health services provider's stock worth $123,000 after buying an additional 305 shares during the period. Finally, DNB Asset Management AS raised its stake in shares of Universal Health Services by 27.3% during the second quarter. DNB Asset Management AS now owns 10,762 shares of the health services provider's stock worth $1,990,000 after buying an additional 2,310 shares during the last quarter. Institutional investors and hedge funds own 86.05% of the company's stock.
UHS opened at $200.95 on Tuesday. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.39 and a quick ratio of 1.28. The company has a market capitalization of $13.26 billion, a price-to-earnings ratio of 13.36, a P/E/G ratio of 0.65 and a beta of 1.29. The business's 50-day moving average price is $214.82 and its two-hundred day moving average price is $207.47. Universal Health Services, Inc. has a 1 year low of $133.70 and a 1 year high of $243.25.
Universal Health Services (NYSE:UHS - Get Free Report) last announced its earnings results on Thursday, October 24th. The health services provider reported $3.71 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $3.75 by ($0.04). The firm had revenue of $3.96 billion during the quarter, compared to analyst estimates of $3.90 billion. Universal Health Services had a net margin of 6.66% and a return on equity of 15.75%. The firm's quarterly revenue was up 11.3% compared to the same quarter last year. During the same period in the prior year, the business posted $2.55 EPS. Equities analysts expect that Universal Health Services, Inc. will post 15.93 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Tuesday, December 3rd will be given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 0.40%. The ex-dividend date is Tuesday, December 3rd. Universal Health Services's dividend payout ratio (DPR) is currently 5.32%.
A number of analysts have commented on the stock. UBS Group lifted their target price on shares of Universal Health Services from $247.00 to $267.00 and gave the stock a "buy" rating in a report on Wednesday, August 14th. KeyCorp assumed coverage on Universal Health Services in a research note on Friday, October 11th. They set a "sector weight" rating for the company. Cantor Fitzgerald reiterated a "neutral" rating and issued a $219.00 price objective on shares of Universal Health Services in a report on Friday, October 25th. Royal Bank of Canada reduced their target price on Universal Health Services from $222.00 to $211.00 and set a "sector perform" rating on the stock in a report on Monday, October 28th. Finally, Barclays upped their price target on Universal Health Services from $256.00 to $271.00 and gave the company an "overweight" rating in a research note on Friday, October 25th. Six equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Universal Health Services currently has a consensus rating of "Moderate Buy" and a consensus target price of $225.50.
Read Our Latest Research Report on UHS
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Universal Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Universal Health Services wasn't on the list.
While Universal Health Services currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.